Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: A putative animal model of depression?

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1333-1341

  Hansen, H H ^a   Sanchez C ^a   Meier, E ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 1 (3 DIMETHYLAMINOPROPYL) 1 (4 FLUOROPHENYL)PHTHALAN; CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SOCIAL INTERACTION; SWIMMING; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; BENZOFURANS; BUTYLAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SWIMMING; WEIGHT GAIN;

EID: 0031473315     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. ABEL, E. L.: Gradient of alarm substance in the forced swimming test. Physiol. Behav. 49: 321-323, 1991.
2. ABEL, E. L. AND BILITZKE, P. J.: A possible alarm substance in the forced swimming test. Physiol. Behav. 48: 223-239, 1990.
3. ARMARIO, A., GAVALDÁ, A. AND MERI, O.: Force swimming test in rats: Effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defaecation rate. Eur. J. Pharmacol. 158: 207-212, 1988.
4. ARNT, J., LEMBØL, H. L., MEIER, E. AND PEDERSEN, H.: Discriminative stimulus properties of the muscarinergic receptor agonists Lu 26-046 and O-methyl-THPO in rats: Evidence for involvement of different muscarinic receptor subtypes. Eur. J. Pharmacol. 218: 159-169, 1992.
5. BIGLER, A. J., BØGESØ, K. B. AND TOFT, A.: Quantitative structure-activity relationships in a series of selective 5-HT uptake inhibitors. Eur. J. Med. Chem. 12: 289-295, 1977.
6. BORSINI, F.: Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19: 377-395, 1995.
7. 1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity. J. Med. Chem. 38: 4380-4392, 1995.
8. CALDECOTT-HAZARD, S. AND SCHNEIDER, L. S.: Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies. Synapse 10: 141-169, 1992.
9. DENENBERG, V. H.: Open field behavior in the rat: What does it mean? Ann. NY Acad. Sci. 159: 852-859, 1969.
10. DETKE, M. J., RICKELS, M. AND LUCKI, I.: Active behavior in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121: 66-72, 1995.
11. DWYER, K. D. AND ROY, E. J.: Juvenile desipramine reduces adult sensitivity to imipramine in two behavioral tests. Pharmacol. Biochem. Behav. 45: 201-207, 1993.
12. FERNANDEZ-PARDAL, J. AND HILAKIVI, L. A.: Effect of a low alcohol dose on behavioral 'despair' in rats neonatally treated with antidepressant drugs. Alcohol 6: 93-95, 1989.
13. FILE, S. E.: The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods 2: 219-238, 1980.
14. FILE, S. E.: Animal models for predicting clinical efficacy of anxiolytic drugs: Social behavior. Neuropsychobiology 13: 55-62, 1985.
15. FILE, S. E.: How good is social interaction as a test of anxiety. In Animal Models of Psychiatric Disorders: Selected Models of Anxiety, Depression and Psychosis, ed. by P. Simon, P. Soubrié and D. Wildlocher, pp.151-166, Karger, Basel, 1988.
16. FILE, S. E. AND TUCKER, J. C.: Neonatal clomipramine treatment in the rat does not affect social, sexual, and exploratory behavior in adulthood. Neurobiobehav. Toxicol. Teratol. 5: 3-8, 1983.
17. GOODMAN, I. J., BEELER, L. AND AZZARO, A. J.: Development of episodic stress reactions in adult rats treated neonatally with an antidepressant. Soc. Neurosci. Abstr. 19: 664.16, 1993.
18. HALL, H. AND OGREN, S. O.: Effects of antidepressant drugs in histamine H1 receptors in the brain. Life Sci. 34: 597-605, 1984.
19. HARTLEY, P., NEILL, D., HAGLER, M., KORS, D. AND VOGEL, G.: Procedure- and age-dependent hyperactivity in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14: 69-72, 1990.
20. 2 receptors in the caudate/putamen. J. Neural Transm. 102: 139-148, 1995.
21. HILAKIVI, L. A., SINCLAIR, J. D. AND HILAKIVI, I. T.: Effects on neonatal treatment with clomipramine on adult ethanol related behavior in the rat. Dev. Brain. Res. 15: 129-132, 1984.
22. HYTTEL, J.: Citalopram: Pharmacological profile of a specific serotonin-uptake inhibitor with antidepressant activity. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 6: 277-295, 1982a.
23. HYTTEL, J.: Preferential labeling of adenylate cyclase coupled dopamine receptors with thioxanthene neuroleptics. In Advances in Dopamine Research: Advances in the Biosciences, ed. by M. Kohsaka, T. Shohmori, Y. Tsukada and G. N. Woodruff, pp. 147-152, Pergamon Press Ltd., Oxford, 1982b.
24. HYTTEL, J.: Effect of prolonged treatment with neuroleptics on dopamine D-1 and D-2 receptor density in corpus striatum in mice. Acta Pharmacol. Toxicol. 59: 387-391, 1986.
25. 3H-dopamine accumulation in rat striatal synaptosomes by psychotropic drugs. Biochem. Pharmacol. 27: 1063-1069, 1987a.
26. 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60: 13-18, 1987b.
27. 2 receptors in corpus striatum of rats. Pharmacol. Toxicol. 61: 126-129, 1987c.
28. HYTTEL, J.: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 9: 19-26, 1994.
29. 3H]SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. J. Neural Transm. 68: 171-189, 1987.
30. HYTTEL, J. AND LARSEN, J. J.: Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline and serotonin. J. Neurochem. 44: 1615-1622, 1985.
31. HYTTEL, J., ARNT, J., BØGESØ, K., CHRISTIANSEN, A. V., LARSEN, J.-J., LEMBØL, H. L., MEIER, E. AND SÁNCHEZ, C.: Neurochemical and behavioral profile of Lu 17-133, (±)-trans-4-[3,4-dichlorophenyl)-indan-1-yl]-1-piperazineethanol, an inhibitor of the uptake of dopamine and noradrenaline. Drug Dev. Res. 13: 213-230, 1988a.
32. 2-receptor antagonist. Drug. Dev. Res. 15: 389-404, 1988b.
33. HYTTEL, J., OVERØ, K. F. AND ARNT, J.: Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83: 20-27, 1984.
34. IGVY-MAY, N., TAMIR, H. AND GERSHON, M. D.: Synaptic properties of serotonergic growth cones in developing rat brain. J. Neurosci. 14: 1101-1029, 1994.
35. JACOBS, B. L. AND AZMITIA, E. C.: Structure and function of the brain serotonergic system. Physiol. Rev. 72: 165-229, 1992.
36. KELLY, J. P. AND LEONARD, B. E.: The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33: 1101-1106, 1994.
37. KIRBY, L. G, ALLEN, A. R. AND LUCKI, I.: Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 682: 189-196, 1995.
38. KREISS, D. S. AND LUCKI, E.: Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274:866-876, 1995.
39. LAUDER, J. M.: Ontogeny of the serotonin system in the rat: Serotonin as a developmental signal. Ann. NY Acad. Sci. 600: 297-313, 1990.
40. LEONARD, B. E.: Serotonin receptors - where are they going? Int. Clin. Psychopharmacol. 9: 7-17, 1994.
41. MAUDHUIT, C., HAMON, M. AND ADRIEN, J.: Electrophysiological activity of raphe dorsalis serotonergic neurons in a possible model of endogenous depression. NeuroReport 6: 281-284, 1995.
42. MEGENS, A. A. P., LEYSEN, J. E., AWOUTERS, F. L. AND NIEMEGEERS, C. J. E.: Further validation of in vivo and in vitro pharmacological procedures for assessing the α1/α2-selectivity of test compounds: (1) α-adrenoceptor antagonists. Eur. J. Pharmacol. 129: 49-55, 1986.
43. MIRMIRAN, M., SCHOLTENS, J., VAN DE POL, N. E., UYLINGS, H. B. M., VAN DER GUGTEN AND BOER, G. J.: Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behavior in the rat. Dev. Brain. Res. 7: 277-286, 1983.
44. MIRMIRAN, M., VAN DE POLL, N. E., CORNER, M. A., VAN OYEN, H. G. AND BOUR, H. L.: Suppression of active sleep by chronic treatment with clomipramine during early postnatal development: Effects upon adult sleep and behavior in the rat. Brain Res. 204: 129-146, 1981.
45. NEILL, D., VOGEL, G., HAGLER, M., KORS, D. AND HENNESEY, A.: Diminished sexual activity in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14: 73-76, 1990.
46. PORSOLT, R. D., ANTON, G., BLAVET, N. AND JALFRE, M.: Behavioral despair in rats: A new animal model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47: 379-391, 1978.
47. PORSOLT, R. D., LE PICHON, M. AND JALFRE, M.: Depression: A new animal model sensitive to antidepressive treatments. Nature 266: 730-732, 1977.
48. PUCILOWSKI, O. AND OVERSTREET, D. H.: Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res. Bull. 32: 471-475, 1993.
49. RISCH, S. C. AND NEMEROFF, C. B.: Neurochemical alterations of serotonergic neural systems in depression. J. Clin. Psych. 53: 3-7, 1992.
50. RUBIN, B., MALONE, M. H., WAUGH, M. H. AND BURKE, J. C.: Bioassay of rauwolfia roots and alkaloids. J. Pharmacol. Exp. Ther. 120: 125-136, 1957.
51. SAMS-DODD, F.: Automation of the social interaction test by a video-tracking system: behavioral effects of repeated phencyclidine treatment. J. Neurosci. Methods 59: 157-167, 1995.
52. VELASQUEZ-MOCTEZUMA, J., AGUILAR-GARCIA, A. AND DIAZ-RUIZ, O.: Behavioral effects of neonatal treatment with clomipramine, scopolamine and idaxozane in male rats. Pharmacol. Biochem. Behav. 46: 215-217, 1993a.
53. VELASQUEZ-MOCTEZUMA, J., RIUZ, L. A. AND MALDONADO, C.: Perinatal treatment with clomipramine inhibits the facilitatory effects of oxotremorine on masculine sexual behavior in rats. Pharmacol. Biochem. Behav. 42: 737-739, 1992.
54. VELASQUEZ-MOCTEZUMA, J., RUIZ, L. A. AND MOLDONADO, C.: Perinatal treatment with clomipramine inhibits the facilitatory effects of oxotremorine on masculine sexual behavior in rats. Soc. Neurosci. Abstr. 19: 242.11, 1993b.
55. VOGEL, G., HARTLEY, P., NEILL, D., HAGLER, M. AND KORS, D.: Animal depression model by neonatal clomipramine: Reduction of shock-induced aggression. Pharmacol. Biochem. Behav. 31: 103-106, 1988.
56. VOGEL, G., NEILL, D., KORS, D. AND HAGLER, M.: REM sleep abnormalities in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14: 77-83, 1990a.
57. VOGEL, G., NEILL, D., HAGLER, M., KORS, D. AND HARTLEY, P.: Decreased intra-cranial self-stimulation in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14: 65-68, 1990b.
58. VOGEL, G., NEILL, D., HAGLER, M. AND KORS, D.: A new animal model of endogenous depression: A summary of present findings. Neurosci. Biobehav. Rev. 14: 85-91, 1990c.
59. WALSH, R. N. AND CUMMINS, R. A.: The open field test: A critical review. Psychol. Bull. 83: 482-504, 1976.
60. WEST, A. P.: Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14: 863-877, 1990.
61. YAVARI, P., VOGEL, G. AND NEILL, D.: Decreased raphe unit activity in a rat model of endogenous depression. Brain Res. 611: 31-36, 1993.